Clin Infect Dis

1. BERENGUER J, Ryan P, Lutz T, Martin-Carbonero L, et al
   Adherence to Hepatocellular Carcinoma Surveillance Guidelines Among People with HIV and Chronic HBV Infection.
   Clin Infect Dis. 2026 Jun 1:ciag341. doi: 10.1093.
   

   >> Share

   
   

   
   J Med Virol

2. ZHANG J, Lin Y, Zhu Y
   Development and Validation of a Nomogram to Predict Recompensation in Patients With HBV-Related Acute-on-Chronic Liver Failure: A Multicenter Retrospective Study.
   J Med Virol. 2026;98:e71195.
   

   >> Share

   
   
3. DENG H, Liang X, Qiu J, Dang S, et al
   HBV PreS Variants Significantly Decrease in Liver Tissues After 104 Weeks of Antiviral Therapy With Nucleos(t)ide Analogues.
   J Med Virol. 2026;98:e71189.
   

   >> Share

   
   

   
   J Viral Hepat

4. LIU L, Li M, Zhu S, Dong Y, et al
   Real-World Effectiveness and Safety of Sofosbuvir-Based Therapy in Chinese Children and Adolescents With Chronic HCV Infection: A Retrospective Multicentre Study.
   J Viral Hepat. 2026;33:e70253.
   

   >> Share

   
   
5. DEBNATH M, Jayaswal RP
   From Detecting Lesions to Delivering Care: Point-of-Care Ultrasound in Hepatitis B.
   J Viral Hepat. 2026;33:e70256.
   

   >> Share

   
   
6. ASSELAH T, Kakuda TN, Kulke S, Walenta E, et al
   A Randomized, Double-Blind, Placebo-Controlled Study of the PD-1 Inhibitor Cetrelimab in Chronic Hepatitis B.
   J Viral Hepat. 2026;33:e70246.
   

   >> Share

   
   
7. REN D, Dang X, Fu S, Zhang Z, et al
   Renal Safety and Antiviral Effectiveness of Tenofovir Alafenamide Versus Entecavir in Patients With Chronic Hepatitis B and Chronic Kidney Disease: A Real-World Cohort Study.
   J Viral Hepat. 2026;33:e70235.
   

   >> Share

   
   
8. HAN WM, Solomon S, Wagner-Cardoso S, Li J, et al
   Rare and Novel Hepatitis C Virus Genotype Subtypes and Response to Sofosbuvir/Velpatasvir in A5360 (MINMON) Clinical Trial.
   J Viral Hepat. 2026;33:e70251.
   

   >> Share

   
   

   
   Proc Natl Acad Sci U S A

9. PHELPS CC, Smith S, Gridley J, Kohout JA, et al
   Hepatitis C viral variants bear signatures of de novo CD8+ T cell and antibody pressure after spontaneous postpartum viral suppression.
   Proc Natl Acad Sci U S A. 2026;123:e2610110123.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share